Methotrexate

Methotrexate Reactions 1680, p222 - 2 Dec 2017 Herpes simplex type 2 encephalitis: case report A 79-year-old man developed herpes simplex virus type-2 (HSV-2) encephalitis during treatment with methotrexate. The man, who had a history of peripheral spondyloarthritis (HLA-B27-positive), was receiving methotrexate 20 mg/week for two years [route not stated]. He was hospitalised for with a 4-day history of acute confusion, aphasia, fever and temporospatial disorientation. An EEG revealed slow wave activity. His CSF specimen showed protein level of 2.7 g/L, WBC count of 56 cells/mm (20% neutrophils and 80% lymphocytes) and glucose level of 4.2 mmol/L. The man was empirically treated with ceftriaxone, acyclovir and cotrimoxazole [sulfamethoxazole/trimethoprim]. Polymerase chain reaction (PCR) detected HSV-2 DNA in the CSF (HSV-2 load, 5.37 log10 copies/mL). Methotrexate and antibiotics were discontinued and acyclovir was continued. The PCR for Epstein-Barr virus (EBV) DNA was positive in the CSF with a viral load of 2.7 log10 copies/mL. The EBV serology showed a past infection and the possibility of EBV reactivation was considered. Two serum samples were taken at admission and two weeks later were retrospectively analysed with a commercially available HSV type-specific serological assay. Both of the serum samples examination were positive for HSV-2 IgG antibodies. On day 2, he went in coma (Glasgow Coma Score 8/15), but no abnormalities were observed on CT scan and EEG. He required sedation and mechanical ventilation support for six days. There was a significant improvement in his condition. An MRI of brain one month after the start of treatment showed abnormal signal hyperintensity on T2 imaging involving the right inferior temporal gyrus. One month after the onset of the encephalitis, he was discharged. A follow-up at six months after the discharge showed that he still experienced memory impairment and concentration disorders. His wife observed a change in personality in her husband, along with aggressive behaviour. Author comment: ’’In conclusion, although suspected, the role of lowdose [methotrexate] therapy as a risk factor of this rare case of HSV-2 encephalitis needs further evaluation.’’ Lupo J, et al. Herpes simplex type 2 encephalitis and methotrexate medication: A fortuitous or causative association in a patient with spondyloarthritis?. Antiviral Therapy 22: 357-359, No. 4, 2017. Available from: URL: http://doi.org/10.3851/ IMP3110 - France 803284285 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Methotrexate

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/methotrexate-FkMJ7WkKoJ
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39153-4
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial